You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠集團(000513.SZ):麗珠新北江與焦作健康元擬共設河南省健康元生物醫藥研究院
格隆匯 11-30 21:05

格隆匯 11 月 30日丨麗珠集團(000513.SZ)公佈,20201130日,公司控股附屬公司麗珠集團新北江製藥股份有限公司(“麗珠新北江”)與控股股東健康元藥業集團股份有限公司(“健康元集團”)全資子公司焦作健康元生物製品有限公司(“焦作健康元”)簽署了《焦作健康元生物製品有限公司與麗珠集團新北江製藥股份有限公司關於設立河南省健康元生物醫藥研究院有限公司之共同投資協議》,麗珠新北江與焦作健康元擬共同以現金方式投資設立合資公司河南省健康元生物醫藥研究院有限公司(“合資公司”),合資公司註冊資本為人民幣1億元,其中,麗珠新北江認繳出資4900萬元,佔比49%,焦作健康元認繳出資5100萬元,佔比51%

合資公司的經營宗旨為:採用先進而適用的技術和科學的經營管理方法,提高產品質量,發展新產品,並在質量、價格等方面加強國際市場上的競爭能力,提高經濟效益,使全體股東獲得滿意的投資回報。

次麗珠新北江與焦作健康元共同投資設立合資公司,是為了集聚和強化外部研發人才資源和研發能力,重點集中在生物醫藥中間體及高端特色原料藥的創新研發工作上。此次投資將有利於促進本公司原料藥業務研發實力的提升與新方向、新領域佈局,進而提高公司的核心競爭力及可持續發展實力

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account